Skip to content
Drix10 Blog

Brown fat study links active brown fat to mental health

, 2 items in Neuroscience and AI, 2 min read

In this digest (2 items)

lonvo-z phase 3 trial shows lower attack rate

lonvo-z in a phase 3 randomized trial lowered hereditary angioedema attack rate versus placebo. The trial compared lonvo-z to placebo in patients with hereditary angioedema.

Key points

  • Trial: phase 3, randomized trial of lonvo-z.

  • Result: lower attack rate for patients receiving lonvo-z than for placebo.

Sources